Bruker (BRKR) reported Q3 non-GAAP earnings Tuesday of $0.60 per diluted share, down from $0.74 a year earlier.
Analysts polled by Capital IQ expected $0.60 per share.
Revenue in the quarter ended Sept. 30 was $864.4 million, up from $742.8 million a year earlier.
Analysts surveyed by Capital IQ expected $866.1 million.
The company lowered its outlook for 2024 non-GAAP EPS to $2.36 to $2.41, from $2.59 to $2.64 previously. Analysts surveyed by Capital IQ expect $2.60.
Bruker expects 2024 revenue of $3.34 billion to $3.37 billion, compared with $3.38 billion and $3.44 billion previously. Analysts polled by Capital IQ expect $3.40 billion.
Bruker shares fell by more than 6% in premarket trading.
Price: 55.99, Change: -3.36, Percent Change: -5.66
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.